Kemnay Advisory Services’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
Other funds holding LGND
JT
CAM
Kemnay Advisory Services's LGND Position: Q2 2026 in Review
Kemnay Advisory Services increased its Ligand Pharmaceuticals (LGND) stake by 9.9% in Q2 2026, buying an estimated $3.77K and bringing the position to 177 shares worth $55.9K. The position accounts for 0.01% of the portfolio, ranked #263.
Kemnay Advisory Services first reported a position in LGND in Q4 2025 and has held it in 3 quarters since. 416 funds tracked by Wall St. Rank hold LGND as of Q2 2026.
- Kemnay Advisory Services held 177 shares of Ligand Pharmaceuticals worth $55.9K as of Q2 2026.
- Kemnay Advisory Services bought 16 Ligand Pharmaceuticals shares in Q2 2026, an estimated $3.77K.
- Ligand Pharmaceuticals made up 0.01% of Kemnay Advisory Services's portfolio in Q2 2026, its #263 holding.
- Kemnay Advisory Services first reported a position in Ligand Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
- 416 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q2 2026.
Based on Kemnay Advisory Services's 13F filing for Q2 2026, filed 14 Aug 2026.